Utility of the Plasma Level of suPAR in Monitoring Risk of Mortality during TB Treatment

• Paulo Rabna,

  Affiliation Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau

  ⨯
• Andreas Andersen,

  Affiliation Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau

  ⨯
• Christian Wejse,

  Affiliations Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau, Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark, Center of Global Health, School of Public Health, Aarhus University, Aarhus, Denmark

  ⨯
• Ines Oliveira,

  Affiliation Clinical Research Centre, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark

  ⨯
• Victor Francisco Gomes,

  Affiliation Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau

  ⨯
• Maya Bonde Haaland,

  Affiliation Center of Global Health, School of Public Health, Aarhus University, Aarhus, Denmark

  ⨯
• Peter Aaby,

  Affiliations Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau, Bandim Health Project, Statens Serum Institute, Copenhagen, Denmark

  ⨯
• Jesper Eugen-Olsen

  * E-mail: jespereugenolsen@gmail.com

  Affiliation Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau

  ⨯